Literature DB >> 3279952

Inhibition of cathepsin L-induced degradation of epidermal growth factor receptors by c-Ha-ras gene products.

T Hiwasa1, S Sakiyama, S Yokoyama, J M Ha, J Fujita, S Noguchi, Y Bando, E Kominami, N Katunuma.   

Abstract

The inhibitory activities of c-Ha-ras gene products (p21s) toward several cysteine proteinases have been investigated. The activity of cathepsin L was inhibited by p21s most effectively while those of cathepsin B and papain were slightly inhibited by p21s. p21s did not show any inhibitory activity toward cathepsin H. In order to connect the protease-inhibitor activity of p21s with cell growth, the degradation of epidermal growth factor receptors (EGF-receptors) was investigated. EGF-receptors were preferentially cleaved by cathepsin L but not by cathepsin B or H. The cleavage of EGF-receptors by cathepsin L was inhibited by p21s dose-dependently. These results raise the possibility that p21s can suppress the degradation of growth-related proteins such as EGF-receptors and thereby affect cell growth.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279952     DOI: 10.1016/0006-291x(88)90561-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Internally repeated sequences in ras gene products.

Authors:  T Hiwasa
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

Review 2.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

3.  Molecular mechanisms of ubiquitin-dependent membrane traffic.

Authors:  James H Hurley; Harald Stenmark
Journal:  Annu Rev Biophys       Date:  2011       Impact factor: 12.981

Review 4.  Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.

Authors:  Janko Kos; Ana Mitrović; Milica Perišić Nanut; Anja Pišlar
Journal:  FEBS Open Bio       Date:  2022-02-03       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.